human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
hepi
novel
transcript
repressor
express
profil
promot
activ
well
studi
present
studi
situ
hybrid
rna
use
studi
differenti
hepi
express
level
differ
type
cancer
normal
tissu
total
six
truncat
length
hepi
promot
regulatori
sequenc
clone
vector
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
dual
luciferas
report
assay
perform
result
rtqpcr
demonstr
hepi
express
level
differ
across
four
breast
cancer
cell
line
result
dual
luciferas
report
assay
reveal
activ
report
gene
fragment
span
bp
higher
compar
report
gene
fragment
span
bp
search
transcript
factor
databas
transfac
identifi
numer
octam
transcript
nuclear
factor
nf
cjun
transcript
factor
bind
site
locat
hepi
promot
phepi
furthermor
result
reveal
mutat
bp
bp
cjun
bp
site
human
phepi
result
decreas
luciferas
activ
chromatin
immunoprecipit
assay
reveal
cjun
bound
phepi
sitedepend
manner
basal
state
transfac
databas
use
analyz
phepi
multipl
speci
sever
activ
transcript
factor
bind
site
predict
conclus
result
present
studi
suggest
hepi
express
differ
level
multipl
organ
breast
cancer
cell
line
furthermor
find
indic
cjun
transcript
factor
associ
transcript
regul
hepi
gene
human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
sarscov
hepi
gene
novel
gene
initi
discov
hong
et
al
cdna
librari
human
embryo
lung
tissu
hepi
protein
abl
interact
sarscov
sarscov
produc
coronaviru
main
proteas
cleav
polyprotein
infect
protein
abl
function
viral
transcriptas
hepi
protein
consist
amino
acid
sever
casein
kinas
ii
phosphoryl
site
previou
studi
hepi
demonstr
interact
specif
tata
sequenc
heat
shock
protein
promot
suggest
hepi
may
associ
gene
transcript
regul
howev
express
profil
promot
activ
hepi
yet
elucid
chang
express
specif
gene
product
regul
wide
rang
mechan
includ
transcript
translat
regul
octam
transcript
nuclear
factor
activ
protein
import
transcript
factor
serv
role
cancer
cell
prolifer
surviv
transform
invas
metastasi
angiogenesi
chemotherapyradiotherapi
resist
oct
class
transcript
factor
bind
atttgcat
sequenc
gene
promot
also
term
ubiquit
express
transcript
factor
contain
pou
domain
homeobox
subdomain
serv
import
regulatori
role
cellular
transcript
via
bind
specif
promot
octam
sequenc
target
gene
furthermor
bind
cofactor
interact
pou
dnabind
domain
either
posit
neg
regul
varieti
gene
previou
studi
report
affect
occurr
develop
sever
cancer
includ
breast
cancer
lncap
prostat
cancer
esophag
squamou
cell
carcinoma
colorect
cancer
dimer
transcript
factor
belong
famili
form
heteroor
homodimer
known
serv
vital
role
regul
inflamm
immun
cell
prolifer
apoptosi
dimer
transcript
activ
compos
jun
fo
activ
transcript
factor
musculoaponeurot
fibrosarcoma
protein
subunit
serv
import
role
regul
cellular
prolifer
transform
differenti
apoptosi
via
bind
common
site
target
gene
promot
present
studi
situ
rna
hybrid
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
use
detect
hepi
gene
express
profil
sever
organ
tissu
breast
cancer
cell
line
promot
activ
hepi
gene
also
investig
first
step
identifi
core
hepi
promot
enabl
subsequ
determin
import
transcript
factor
promot
region
transcript
factor
bind
site
hepi
gene
predict
bioinformat
analysi
bind
site
hepi
promot
region
identifi
use
sitedirect
mutagenesi
dual
luciferas
report
assay
chromatin
immunoprecipit
chip
assay
respect
rna
situ
hybrid
dna
microarray
contain
sampl
case
tumor
normal
tissu
obtain
shaanxi
chaoy
biotechnolog
co
ltd
cat
xian
china
sampl
follow
organ
esophagu
stomach
colon
rectum
liver
lung
kidney
breast
uterin
cervix
ovari
prostat
pancrea
core
posit
cancer
core
adjac
normal
tissu
organ
one
cancer
tissu
core
one
adjac
normal
tissu
core
per
case
follow
sens
antisens
probe
match
hepi
core
respond
sequenc
use
antisens
digoxigenin
dig
tct
gcc
cat
atg
tca
gga
ttg
gaa
ata
atg
gat
sens
digatc
cat
tat
ttc
caa
tcc
tga
cat
atg
ggc
probe
synthes
sangon
biotech
co
ltd
shanghai
china
hybrid
procedur
perform
previous
describ
stain
score
use
scale
stain
indic
increas
intens
stain
subregion
exclud
necrosi
macrophag
infiltr
neutrophil
lymphocyt
select
score
intens
score
array
spot
mean
subregion
cell
cultur
cell
china
center
type
cultur
collect
wuhan
china
maintain
highglucos
dulbecco
modifi
eagl
medium
gibco
thermo
fisher
scientif
inc
waltham
usa
supplement
fetal
bovin
serum
hyclon
ge
healthcar
life
scienc
logan
ut
usa
incub
co
cell
seed
densiti
cellswel
plate
quantit
chip
assay
cell
seed
densiti
cellswel
plate
luciferas
assay
rtqpcr
total
rna
extract
breast
cancer
cell
use
trizol
reagent
invitrogen
thermo
fisher
scientif
inc
accord
manufactur
protocol
extract
total
rna
per
sampl
use
synthes
firststrand
cdna
use
revers
transcript
system
kit
promega
corpor
madison
wi
usa
accord
manufactur
protocol
primer
use
pcr
follow
hepi
forward
tgg
ctc
agt
ttg
revers
aag
att
tcc
tcc
gapdh
forward
ctt
caa
cag
cga
cac
revers
cct
gtt
gct
gta
gcc
gapdh
use
intern
control
qpcr
perform
use
sybr
master
mixtur
takara
biotechnolog
co
ltd
dalian
china
accord
manufactur
protocol
use
follow
cycl
condit
sec
follow
cycl
sec
sec
express
hepi
analyz
previous
describ
pcr
amplif
reaction
system
condit
pcr
product
purifi
previous
describ
purifi
product
clone
xhoi
ctcgag
hindiii
aagctt
restrict
enzym
site
vector
promega
corpor
use
dna
ligas
sangon
biotech
co
ltd
accord
manufactur
protocol
present
studi
transcript
factor
databas
transfac
wwwcbrcjpresearchdbtfsearchhtml
use
search
sever
transcript
factorbind
site
predict
within
hepi
promot
region
sitedirect
mutagenes
neg
number
indic
upstream
transcript
initi
site
cjun
bind
site
hepi
promot
perform
use
quick
chang
sitedirect
mutagenesi
kit
stratagen
agil
technolog
inc
santa
clara
ca
usa
accord
manufactur
protocol
use
follow
primer
transfect
dual
luciferas
report
assay
cell
cotransfect
vector
b
prltk
promega
corpor
plasmid
dnawel
plate
use
lipofectamin
invitrogen
thermo
fisher
scientif
inc
accord
manufactur
protocol
luciferas
activ
extract
assess
h
follow
transfect
use
betascop
analyz
infinit
tecan
group
ltd
switzerland
analyz
previous
describ
prltk
plasmid
contain
renilla
luciferas
gene
use
intern
control
statist
analysi
statist
analysi
perform
use
spss
softwar
spss
inc
chicago
il
usa
data
present
mean
standard
deviat
student
ttest
oneway
analysi
varianc
follow
dunnett
test
use
analyz
data
p
consid
indic
statist
signific
differ
hepi
express
profil
detect
rna
situ
hybrid
tissu
microarray
hepi
express
esophag
squamou
cell
carcinoma
rectal
adenocarcinoma
tissu
opposit
normal
esophag
rectal
tissu
tabl
fig
hepi
express
posit
esophag
squamou
cell
carcinoma
neg
normal
esophag
tissu
wherea
posit
normal
rectal
tissu
neg
rectal
adenocarcinoma
hepi
posit
express
tumor
normal
tissu
stomach
liver
colon
prostat
lung
uterin
cervix
pancrea
tabl
express
hepi
posit
tumor
normal
tissu
kidney
ovari
neg
other
hepi
posit
express
nonspecif
infiltr
duct
carcinoma
breast
partial
posit
express
observ
normal
breast
tissu
hepi
express
level
four
human
breast
cancer
cell
line
examin
use
rtqpcr
fig
express
hepi
significantli
increas
osteolyt
breast
cancer
cell
line
compar
cell
hepi
mrna
level
cell
higher
compar
cell
p
cell
higher
compar
cell
p
result
suggest
hepi
express
differ
level
variou
organ
breast
cancer
cell
line
clone
activ
human
hepi
promot
understand
mechan
hepi
gene
transcript
express
dual
luciferas
report
assay
use
detect
hepi
promot
activ
total
six
differ
truncat
length
hepi
promot
regulatori
sequenc
amplifi
pcr
product
clone
vector
fig
dual
luciferas
report
assay
analysi
six
recombin
plasmid
reveal
bp
report
gene
fragment
exhibit
higher
activ
level
compar
p
bp
bp
report
gene
fragment
exhibit
higher
activ
level
compar
p
fig
mutat
transcript
factor
bind
site
luciferas
activ
analysi
investig
whether
put
respons
element
regul
transcript
hepi
fig
suggest
cjun
activ
report
furthermor
cjun
bind
element
hepi
promot
simultan
mutat
gener
three
site
mutat
promot
activ
significantli
decreas
compar
p
fig
howev
level
suppress
three
mutat
exceed
combin
level
suppress
individu
point
mutat
suggest
three
mutat
act
jointli
taken
togeth
result
suggest
cjun
site
serv
import
role
inhibit
transcript
activ
hepi
identifi
transcript
factor
bind
site
within
hepi
promot
region
import
determin
mechan
hepi
gene
transcript
determin
whether
cjun
abl
bind
endogen
hepi
promot
chip
assay
perform
investig
transcript
factor
bind
result
indic
cjun
bind
endogen
hepi
promot
cell
suggest
may
serv
import
role
regul
hepi
express
fig
analysi
hepi
promot
multipl
speci
tabl
ii
list
put
hepi
promot
among
variou
speci
b
dual
luc
activ
assay
mutat
phepi
construct
total
six
recombin
vector
contain
mutat
phepi
fragment
prltk
cotransfect
cell
p
luc
luciferas
phepi
human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
promot
octamerbind
transcript
factor
nuclear
hepi
human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
octamerbind
transcript
factor
nuclear
activ
protein
sequenc
length
hepi
promot
conserv
among
vertebr
fig
sequenc
homo
sapien
human
hepi
promot
share
highest
homolog
pan
troglodyt
chimpanze
hepi
promot
rattu
norvegicu
norway
rat
mu
musculu
hous
mice
bo
tauru
cattl
chimpanze
human
cani
lupu
familiari
dog
macaca
mulatta
rhesu
monkey
analyz
use
transfac
sever
cjun
cfo
transcript
factor
bind
site
predict
within
promot
region
tabl
ii
previous
report
hepi
abl
inhibit
prolifer
hela
cell
may
serv
antioncoprotein
hepi
also
abl
inhibit
express
chloramphenicol
acetyltransferas
gene
may
function
factor
transcript
repress
aim
present
studi
determin
express
profil
hepi
gene
elucid
mechan
hepi
transcript
level
differ
rna
situ
hybrid
rish
method
identifi
mrna
transcript
express
pattern
within
cytoplasm
hybrid
sequenc
interest
label
probe
probe
includ
radioact
probe
nonradioact
probe
rish
experi
perform
nonradioact
probe
sever
advantag
radioact
procedur
includ
signal
resolut
safeti
shelflif
cost
due
limit
avail
hepi
antibodi
express
hepi
gene
cancer
adjac
normal
tissu
organ
assess
use
rna
situ
hybrid
specif
digoxigeninlabel
probe
howev
due
limit
number
specimen
avail
necessari
increas
number
specimen
analyz
order
obtain
accur
result
hepi
express
level
four
human
breast
cancer
cell
line
examin
use
rtqpcr
howev
hepi
express
type
cell
line
remain
unknown
determin
differenti
express
hepi
allow
analysi
function
varieti
diseas
promot
control
gene
transcript
may
locat
upstream
gene
transcript
start
site
long
bind
transcript
factor
promot
import
mechan
gene
express
control
investig
hepi
promot
activ
reveal
luciferas
activ
vari
suggest
transcript
regul
occur
bp
region
promot
furthermor
result
suggest
mutat
cjun
ttg
agt
cagg
bp
cta
ttt
gct
tctg
bp
gga
atc
ccct
bp
result
mark
reduct
luciferas
activ
indic
cjun
activ
howev
signific
chang
luciferas
activ
observ
follow
truncat
bp
bp
region
result
suggest
bp
bp
region
also
contain
repressorbind
site
find
present
studi
indic
appar
chang
transcript
activ
hepi
gene
may
result
complex
interact
differ
transcript
factor
promot
associ
hepi
gene
transcript
factor
mayb
widespread
therefor
studi
requir
present
studi
sequenc
analysi
identifi
numer
transcript
factorbind
site
within
hepi
promot
sequenc
cjun
ubiquit
express
previous
report
serv
varieti
role
progress
numer
cancer
result
chip
assay
indic
cjun
abl
bind
endogen
hepi
promot
cell
sever
figur
homolog
tree
hepi
promot
upstream
hepi
gene
hepi
human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
figur
bind
cjun
endogen
phepi
promot
analyz
use
chromatin
immunoprecipit
assay
cell
amplifi
phepi
fragment
cjun
element
present
amount
dna
input
confirm
equal
load
chromatin
indic
posit
control
templat
genom
dna
fragment
cell
use
octamerbind
transcript
factor
nuclear
phepi
human
embryo
lung
cellular
protein
interact
sever
acut
respiratori
syndromecoronaviru
nonstructur
promot
cjun
cfo
transcript
factorbind
site
predict
within
put
hepi
promot
variou
speci
conclus
result
present
research
reveal
hepi
differ
express
level
multipl
type
cancer
normal
tissu
four
breast
cancer
cell
line
cjun
transcript
factor
associ
transcript
regul
hepi
gene
find
provid
insight
express
profil
mechan
hepi
gene
transcript
regul
